ImmunoGen CFO David Johnston Steps Down

(RTTNews) - ImmunoGen Inc. (IMGN), Monday said its Chief Financial Officer David Johnston has stepped down, with immediate effect.

Johnston will remain employed with the company through the end of 2018 and thereafter will serve as a consultant to provide transitional support. David Foster, Vice President of Finance and Chief Accounting Officer, will continue to oversee ImmunoGen's Finance and Accounting functions.

Mark Enyedy, President and Chief Executive Officer, will serve on an interim basis as principal financial officer, as well as lead its Investor Relations function.

"We thank Dave for his many contributions to ImmunoGen over the last five years," said Mark Enyedy. "He has built a first-rate Finance team, continued to ensure a strong balance sheet and disciplined investment strategy, and provided exceptional leadership in a number of areas integral to our transition to a fully integrated biotechnology company, including strategic planning, investor relations, and financing transactions. We wish him the best in his future."